genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2016
AbbVie
Industry News
AbbVie to Acquire Stemcentrx for Up to $9.8B
Cancer
AbbVie to Co-Commercialize CytomX’s Probody Drug Conjugates
Drug Discovery
AbbVie to Co-Develop Argen-X’s Cancer Immunotherapy ARGX-115
Industry News
ImmunogenX Acquires Celiac Disease Candidate from Alvine Pharmaceuticals
Industry News
AbbVie, Boehringer Ingelheim Launch $595M+ Collaboration to Develop Phase III Psoriasis Candidate
Genome Editing
AbbVie Launches IBD Collaboration with Synlogic
Cancer
MD Anderson Partners with AbbVie in Cancer “Moon Shots”
Drug Discovery
Lilly, Halozyme Begin Up-to-$800M+ Platform Partnership
A-Lists
Top 10 Pharma Firms of 2015
News
AbbVie Advancing ABT-494 for Arthritis; Ends Galapagos Collaboration
1
...
5
6
7
...
9
Page 6 of 9
Scroll Up